Somatic Cancer Testing

Targeted Genetic Insights for Advanced Cancer Treatment

Somatic cancer testing offers 98%+ accuracy, fast results, and insights on key genes to guide treatment for advanced cancers—helping oncologists choose the best therapies for each patient.

  • Our somatic cancer tests provide targeted genetic insights to guide treatment decisions for advanced, persistent, or recurrent cancers, ensuring patients receive the most effective, personalized therapies.
  • With >98% sensitivity and specificity, our tests analyze key cancer-related genes, including HRD, lung, colorectal, thyroid, and endometrial cancer panels, helping oncologists optimize treatment strategies.
  • Samples are processed in accredited labs in India (Strand) and the US (Tempus) using FFPE tissue biopsy, with results available in as little as 2–4 weeks for precise, guideline-supported clinical decisions.
Product Hero Image
Science Behind It image
Science Behind It

Backed by Science, Built for You

Cancer is a complex heterogenous disease which requires specific treatment for specific cancer profile

Especially for persistent and advanced cancer, targeted and optimized treatment is the patient’s best chance at recovery

With so many treatment options available, how do one choose which for a specific case?

Indication of Use

Who Can Benefit from this?

Although almost all inviduals can take the test, our tests are especially helpful for individuals who have family history

Patients with advanced stage cancer

Patients with persistent or recurring cancer

Cancer patients

Test Performance

Why Choose us

We can help you:

Test Performance image 1

Over 98% of accuracy (sensitivity and specificity)

Product Logistics of the test Image
Logistics of the Test

Fast, Secure, & Science-Backed Testing

Strand

  • Send sample to India
  • Tissue biopsy (FFPE block)

Tempus

  • Send sample to US
  • Tissue biopsy Liquid biopsy (blood)
  • Kit from Tempus
Your Journey

What Happens After You Get Your Results?

Your Journey image 1
Guidelines from Experts

Backed by Science, Trusted by Experts

Guideline image 1

Prostate Cancer

National Comprehensive Cancer Network Guidelines on prostate cancer

Guideline image 2

Non-Small Cell Lung Cancer

National Comprehensive Cancer Network Guidelines on non-small cell lung cancer

What Report Do I Get?

Tempus

Rare cancers make up 22% of cases and often lack targeted treatments. With Comprehensive Genomic Profiling (CGP), patients achieved a 43.8% ORR (Overall Response Rate) in rare cancers and 62.5% ORR in early treatment. Our tests bridge this gap with advanced sequencing and clinical data, guiding precise, personalized care for better outcomes.

Tempus delivers comprehensive genomic profiling for clinical needs.

  • The most comprehensive oncology database in the world
  • Tumor/Normal Matched DNA Sequencing improves accuracy.
  • Automatic Conversion to Liquid Biopsy ensures results if tissue is lacking.
  • RNA Matching improves and expands treatment options
what-you-get-image
Get Your Test Now

Better Health, Backed by Genetics - At the Right Price

Choose the right package for you:

Somatic Cancer Testing image
Somatic Cancer Testing

Book a consultation with our doctor and start your journey with our test.

Find the right DNA test for you and your loved ones

Unlock total genetic insights to guide your health, nutrition, and wellness journey with personalized and preventive precision